Loring Wolcott & Coolidge Fiduciary Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $9.56K | Hold |
|
|||||
|
2025
Q1 | $10.1K | Hold |
|
|||||
|
2024
Q4 | $10.3K | Hold |
|
|||||
|
2024
Q3 | $6.81K | Hold |
|
|||||
|
2024
Q2 | $8.55K | Hold |
|
|||||
|
2024
Q1 | $10.4K | Hold |
|
|||||
|
2023
Q4 | $13K | Sell |
|
|||||
|
2023
Q3 | $613K | Sell |
|
|||||
|
2023
Q2 | $882K | Sell |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $1.38M | Sell |
|
|||||
|
2022
Q3 | $2.73M | Sell |
|
|||||
|
2022
Q2 | $3M | Buy |
|
|||||
|
2022
Q1 | $3.35M | Buy |
|
|||||
|
2021
Q4 | $2.64M | Buy |
|
|||||
|
2021
Q3 | $1.99M | Buy |
|
|||||
|
2021
Q2 | $1.25M | Buy |
|
|||||
|
2021
Q1 | $310K | Buy |
|
|||||
|
2020
Q4 | $6K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $0 | Buy |
|